1. Editor's page

   EditorialNotes Pages: 181 - 182

2. Suppression of estrogens with Aminoglutethimide and hydrocortisone (medical adrenalectomy) as treatment of advanced breast carcinoma: A review

   • R. J. Santen

   Review Pages: 183 - 202

3. Karyotype analysis of a human mammary sarcoma explant in vitro

   • T. R. Chen
   • G. Seman

   Reports Pages: 203 - 208

4. Estradiol stimulates synthesis of a major intracellular protein in a human breast cancer cell line (MCF-7)

   • Dean P. Edwards
   • David J. Adams
   • William L. McGuire

   Reports Pages: 209 - 223

5. The prophylaxis of rat and mouse mammary gland tumorigenesis by suppression of prolactin secretion: A reappraisal

   • Clifford W. Welsch
   • Margaret Goodrich-Smith
   • Leslie Roth

   Reports Pages: 225 - 232

6. Prolactin binding by human mammary carcinoma: Relationship to estrogen receptor protein concentration and patient age

   • Barbara Rae-Venter
   • Takuma Nemoto
   • Thomas L. Dao

   Reports Pages: 233 - 243

7. Oestrogen receptor concentration in primary breast cancer and axillary node metastases

   • Richard Anthony Hawkins
   • Robert Black
   • Andrew Patrick McEwan Forrest

   Reports Pages: 245 - 251

8. Relationship among estrogen receptors, proliferative activity and menopausal status in breast cancer

   • Armando Bertuzzi
   • Maria Grazia Daidone
   • Rosella Silvestrini

   Reports Pages: 253 - 262

9. Tumour steroid hormone synthesis and estrogen receptor status in breast cancer patients

   • R. C. Mason
   • D. A. Burns
   • A. P. M. Forrest

   Reports Pages: 263 - 266

10. Factors affecting dehydroepiandrosterone sulphate levels in human breast secretions

    • W. R. Miller
    • V. Humeniuk
    • A. P. M. Forrest

    Reports Pages: 267 - 272

11. Repeat screening by single oblique view mammography

    • Bengt Lundgren
    • Sören Jakobsson

    Reports Pages: 273 - 280

12. Comment on the surgeon's role in primary breast cancer

    • Percy Helman

    Correspondence Pages: 281 - 281

13. Glycosylated haemoglobin levels in breast cancer patients receiving cytotoxic chemotherapy

    • B. Cantwell
    • I. F. Shirley
    • J. J. Fennelly

    Correspondence Pages: 281 - 282